ImmunoGen Announces Webcast of Presentation at the Piper Jaffray 31st Annual Healthcare Conference
A webcast of the fireside chat will be accessible live through the “Investors & Media” section of the Company’s website, www.immunogen.com; a replay will be available in the same location for approximately two weeks.
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”
Learn more about who we are, what we do, and how we do it at www.immunogen.com.
INVESTOR RELATIONS AND MEDIA